These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6134111)
1. Aluminium toxicity in an infant not on dialysis. Randall ME Lancet; 1983 Jun; 1(8337):1327-8. PubMed ID: 6134111 [No Abstract] [Full Text] [Related]
2. Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy. Davenport A; Ahmad R Scand J Urol Nephrol; 1988; 22(2):159-60. PubMed ID: 3144735 [TBL] [Abstract][Full Text] [Related]
3. What treatment would you advise for a 1-year-old child with chronic renal failure who has been on aluminum hydroxide as a phosphate binder for 6 months and then develops epilepsy and is found to have a grossly raised plasma aluminum concentration? Andreoli SP; Chesney RW; Salusky IB; Sedman AB Pediatr Nephrol; 1990 Jul; 4(4):318. PubMed ID: 2206897 [No Abstract] [Full Text] [Related]
4. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care. Graf H Intensive Care Med; 1988; 14(4):445-6. PubMed ID: 3403784 [No Abstract] [Full Text] [Related]
5. Hyperaluminaemia associated with oral citrate and aluminium hydroxide. Kirschbaum BB; Schoolwerth AC Hum Toxicol; 1989 Jan; 8(1):45-7. PubMed ID: 2714810 [TBL] [Abstract][Full Text] [Related]
6. Dialysis encephalopathy: recovery after interruption of aluminium intake. Poisson M; Mashaly R; Lebkiri B Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750 [No Abstract] [Full Text] [Related]
7. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care. Mackway-Jones K; Cove-Smith R; Lawler P Intensive Care Med; 1987; 13(4):293-4. PubMed ID: 3497185 [TBL] [Abstract][Full Text] [Related]
8. Raised plasma aluminium in an infant on antacid. Puntis JW; Ballantine NE; Durbin GM Lancet; 1989 Oct; 2(8668):923. PubMed ID: 2571845 [No Abstract] [Full Text] [Related]
14. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. O'Donovan R; Baldwin D; Hammer M; Moniz C; Parsons V Lancet; 1986 Apr; 1(8486):880-2. PubMed ID: 2870354 [TBL] [Abstract][Full Text] [Related]
15. Aluminium hydroxide intake: real risk of aluminium toxicity. Cannata JB; Briggs JD; Junor BJ; Fell GS Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1937-8. PubMed ID: 6407646 [No Abstract] [Full Text] [Related]
17. Oral aluminum and neuropsychological functioning. A study of dialysis patients receiving aluminum hydroxide gels. Rosati G; De Bastiani P; Gilli P; Paolino E J Neurol; 1980; 223(4):251-7. PubMed ID: 6157787 [TBL] [Abstract][Full Text] [Related]
18. [Iatrogenic aluminum osteopathy in a uremic infant]. Koch H; Reich H; Franke D; Delling G Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766 [TBL] [Abstract][Full Text] [Related]
19. Plasma aluminium levels in patients on maintenance haemodialysis fall when oral aluminium hydroxide is withdrawn. Wallace MR; Pybus J N Z Med J; 1983 Oct; 96(742):793-5. PubMed ID: 6578451 [TBL] [Abstract][Full Text] [Related]
20. Can aluminium-containing antacid produce dementia? Jobst K; Nagy J Nephron; 1995; 71(4):473. PubMed ID: 8587635 [No Abstract] [Full Text] [Related] [Next] [New Search]